Vermillion: Soliciting Material Under §240.14A-12

The following excerpt is from the company's SEC filing.
Aspira Women’s Health Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check
es that apply
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notificat ion whenever Vermillion makes a similar move, sign up!

Other recent filings from the company include the following:

Vermillion's President and CEO was just granted 5,000 options - Sept. 1, 2022
Vermillion's General Counsel & Secretary just picked up 26,667 shares - Aug. 30, 2022
Vermillion director just picked up 13,332 shares - Aug. 29, 2022
Vermillion's President & CEO just picked up 66,667 shares - Aug. 29, 2022
Jack W. Schuler Living Trust just provided an update on activist position in Vermillion - Aug. 29, 2022

Auto Refresh

Feedback